Montis Financial LLC Takes $228,000 Position in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Montis Financial LLC bought a new stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 2,549 shares of the exchange traded fund’s stock, valued at approximately $228,000.

Several other hedge funds and other institutional investors have also bought and sold shares of the company. EPG Wealth Management LLC boosted its holdings in SPDR S&P Biotech ETF by 152.7% in the third quarter. EPG Wealth Management LLC now owns 460 shares of the exchange traded fund’s stock worth $34,000 after acquiring an additional 278 shares in the last quarter. Tennessee Valley Asset Management Partners acquired a new position in SPDR S&P Biotech ETF during the 4th quarter valued at about $44,000. Wetzel Investment Advisors Inc. bought a new stake in SPDR S&P Biotech ETF during the 4th quarter worth approximately $45,000. Life Planning Partners Inc purchased a new stake in shares of SPDR S&P Biotech ETF in the fourth quarter worth approximately $64,000. Finally, Albion Financial Group UT bought a new position in shares of SPDR S&P Biotech ETF in the fourth quarter valued at approximately $69,000.

SPDR S&P Biotech ETF Trading Up 1.2 %

SPDR S&P Biotech ETF stock traded up $1.01 during trading on Thursday, hitting $88.34. 10,227,276 shares of the company were exchanged, compared to its average volume of 11,705,899. The business’s 50 day moving average is $92.28 and its 200 day moving average is $85.06. SPDR S&P Biotech ETF has a 52 week low of $63.80 and a 52 week high of $103.52. The company has a market capitalization of $6.73 billion, a P/E ratio of 11.47 and a beta of 1.11.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.